Compare CELU & MMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CELU | MMA |
|---|---|---|
| Founded | 2016 | 2013 |
| Country | United States | Australia |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.3M | 13.9M |
| IPO Year | 2019 | 2023 |
| Metric | CELU | MMA |
|---|---|---|
| Price | $1.42 | $0.43 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $6.00 | N/A |
| AVG Volume (30 Days) | ★ 417.2K | 350.6K |
| Earning Date | 05-11-2026 | 05-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $26,550,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $76.00 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.56 | $0.35 |
| 52 Week High | $2.55 | $1.72 |
| Indicator | CELU | MMA |
|---|---|---|
| Relative Strength Index (RSI) | 55.19 | 48.89 |
| Support Level | $1.10 | $0.36 |
| Resistance Level | $1.43 | $0.44 |
| Average True Range (ATR) | 0.12 | 0.03 |
| MACD | -0.03 | 0.00 |
| Stochastic Oscillator | 61.90 | 75.66 |
Celularity Inc is a regenerative and cellular medicine company focused on developing placental-derived allogeneic cell therapies and biomaterial products for the treatment of degenerative diseases, aging-related conditions, cancer, and immune disorders. The company operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. It generates the majority of its revenue from the Degenerative Disease segment.
MMA Inc develops technology solutions for the martial arts and combat sports sector. Its platform is designed to support gyms and related businesses by improving areas such as sales channels, customer onboarding, and member engagement. The platform also connects participants, gyms, and communities within the sector, enabling digital management and interaction.